Eur Neuropsychopharmacol
-
Publication Venue For
- Corrigendum to "Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions. [European Neuropsychopharmacology Volume 48, July 2021, Pages 3-31]".. 50:133-134. 2021
- Assessment of outcomes in autism clinical trials over the course of development.. 48:40-41. 2021
- Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions.. 48:3-31. 2021
- EEG biomarker informed prescription of antidepressants in MDD: a feasibility trial.. 44:14-22. 2021
- The need for paediatric registries to assess long-term brain effects of psychotropic medications: The case of bipolar disorder.. 28:1181-1184. 2018
- Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale.. 25:176-184. 2015
- The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes.. 24:1492-1499. 2014
- Cognition in schizophrenia: summary Nice Consultation Meeting 2012.. 23:769-778. 2013
- Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.. 22:183-199. 2012